Meeting Archive:
Affordable Care Act Open Enrollment: What You Need to Know

Meeting Description:

*This webinar is sponsored by Strongbridge Biopharma

With the December 15th deadline to select an Affordable Care Act (ACA) health plan looming, the National Organization for Rare Disorders (NORD) is holding a webinar to aid rare disease patients and caregivers in navigating what may be a confusing process.

Join NORD's policy team on Wednesday, November 15 at 7pm (Eastern Standard Time) for an educational webinar about the ACA health insurance marketplaces.

This webinar will include: 

  • how to enroll in an insurance plan on before open enrollment ends on December 15, 
  • the difference between federal vs. state exchanges,
  • key dates you need to keep in mind,
  • how your location can influence when and how you sign up,
  • discuss the impact of ACA on the rare disease community,
  • live Q&A.

We look forward to you joining us. 

Date: Wed, Nov 15, 2017
Time: 07:00 PM EST
Duration: 1 hour
Host(s): National Organization for Rare Disorders
 Presenter Information
Speaker Photo


Speaker Photo

Paul Melmeyer serves as the Director of Federal Policy at the National Organization for Rare Disorders (NORD). In this role, Paul engages in federal congressional and regulatory advocacy on behalf of rare disease patients and the organizations that serve them. His overriding mission is to improve the lives of patients with rare diseases and increase incentives for the development of orphan drugs, devices, and diagnostics. Since joining NORD in 2013, Paul has advocated successfully for the passage of various laws and has crafted comments on NORD’s behalf for numerous proposed rules and guidances. Prior to joining NORD, Paul spent time at the Center for American Progress, AARP, and in the Senate.  

Speaker Photo

Tim Boyd is the Director of State Policy for the National Organization for Rare Disorders (NORD). In this role he is responsible for NORD’s public policy advocacy in all 50 states. Prior to joining NORD in 2015, Tim worked on federal, state and global HIV/AIDS policy. Tim has a Master's in Public Health (MPH) from George Washington University.